Leukemia Research
Volume 30, Issue 9 , Pages 1091-1096 , September 2006

Lifelong persistence of AML associated MLL partial tandem duplications (MLL-PTD) in healthy adults

  • Jörg Bäsecke

      Affiliations

    • Department of Hematology and Oncology, University of Goettingen, Goettingen, Germany
    • Corresponding Author InformationCorresponding author at: Department of Hematology and Oncology, University of Göttingen, Robert-Koch-Straße 40, D-37075 Göttingen, Germany. Tel.: +49 551 398535; fax: +49 551 392914.
    • ,
  • Martina Podleschny

      Affiliations

    • Department of Hematology and Oncology, University of Goettingen, Goettingen, Germany
    • ,
  • Robert Clemens

      Affiliations

    • Department of Hematology and Oncology, University of Goettingen, Goettingen, Germany
    • ,
  • Susanne Schnittger

      Affiliations

    • Medizinische Klinik III, University of Munich, Klinikum Großhadern, Munich, Germany
    • ,
  • Volker Viereck

      Affiliations

    • Department of Gynecology and Obstetrics, University of Goettingen, Goettingen, Germany
    • ,
  • Lorenz Trümper

      Affiliations

    • Department of Hematology and Oncology, University of Goettingen, Goettingen, Germany
    • ,
  • Frank Griesinger

      Affiliations

    • Department of Hematology and Oncology, University of Goettingen, Goettingen, Germany

Received 28 September 2005 ,Revised 30 January 2006 ,Accepted 2 February 2006.

References 

  1. Ernst P, Fisher JK, Avery W, Wade S, Foy D, Korsmeyer SJ. Definitive hematopoiesis requires the mixed-lineage leukemia gene. Dev Cell. 2004;6(3):437–443
  2. Dorshkind K, Witte O. Got MLL? Definitive hematopoiesis requires MLL gene expression. Mol Cell. 2004;13(6):765–766
  3. Ziemin-van der Poel S, McCabe NR, Gill HJ, Espinosa R, Patel Y, Harden A, et al. Identification of a gene, MLL, that spans the breakpoint in 11q23 translocations associated with human leukemias. Proc Natl Acad Sci USA. 1991;88(23):10735–10739
  4. Harrison CJ, Cuneo A, Clark R, Johansson B, Lafage-Pochitaloff M, Mugneret F, et al. Ten novel 11q23 chromosomal partner sites. European 11q23 Workshop participants. Leukemia. 1998;12(5):811–822
  5. Rowley JD. Rearrangements involving chromosome band 11Q23 in acute leukaemia. Semin Cancer Biol. 1993;4(6):377–385
  6. So CW, Cleary ML. Dimerization: a versatile switch for oncogenesis. Blood. 2004;104(2):919–922
  7. Schnittger S, Wormann B, Hiddemann W, Griesinger F. Partial tandem duplications of the MLL gene are detectable in peripheral blood and bone marrow of nearly all healthy donors. Blood. 1998;92(5):1728–1734
  8. So CW, Ma ZG, Price CM, Dong S, Chen SJ, Gu LJ, et al. MLL self fusion mediated by Alu repeat homologous recombination and prognosis of AML-M4/M5 subtypes. Cancer Res. 1997;57(1):117–122
  9. Schichman SA, Caligiuri MA, Strout MP, Carter SL, Gu Y, Canaani E, et al. ALL-1 tandem duplication in acute myeloid leukemia with a normal karyotype involves homologous recombination between Alu elements. Cancer Res. 1994;54(16):4277–4280
  10. Yu M, Honoki K, Andersen J, Paietta E, Nam DK, Yunis JJ. MLL tandem duplication and multiple splicing in adult acute myeloid leukemia with normal karyotype. Leukemia. 1996;10(5):774–780
  11. Caligiuri MA, Strout MP, Lawrence D, Arthur DC, Baer MR, Yu F, et al. Rearrangement of ALL1 (MLL) in acute myeloid leukemia with normal cytogenetics. Cancer Res. 1998;58(1):55–59
  12. Schnittger S, Kinkelin U, Schoch C, Heinecke A, Haase D, Haferlach T, et al. Screening for MLL tandem duplication in 387 unselected patients with AML identify a prognostically unfavorable subset of AML. Leukemia. 2000;14(5):796–804
  13. Steudel C, Wermke M, Schaich M, Schakel U, Illmer T, Ehninger G, et al. Comparative analysis of MLL partial tandem duplication and FLT3 internal tandem duplication mutations in 956 adult patients with acute myeloid leukemia. Genes Chromosomes Cancer. 2003;37(3):237–251
  14. Shiah HS, Kuo YY, Tang JL, Huang SY, Yao M, Tsay W, et al. Clinical and biological implications of partial tandem duplication of the MLL gene in acute myeloid leukemia without chromosomal abnormalities at 11q23. Leukemia. 2002;16(2):196–202
  15. Dohner K, Tobis K, Ulrich R, Frohling S, Benner A, Schlenk RF, et al. Prognostic significance of partial tandem duplications of the MLL gene in adult patients 16–60 years old with acute myeloid leukemia and normal cytogenetics: a study of the Acute Myeloid Leukemia Study Group Ulm. J Clin Oncol. 2002;20(15):3254–3261
  16. Ross ME, Mahfouz R, Onciu M, Liu HC, Zhou X, Song G, et al. Gene expression profiling of pediatric acute myelogenous leukemia. Blood. 2004;
  17. Martin ME, Milne TA, Bloyer S, Galoian K, Shen W, Gibbs D, et al. Dimerization of MLL fusion proteins immortalizes hematopoietic cells. Cancer Cell. 2003;4(3):197–207
  18. Whitman SP, Liu S, Vukosavljevic T, Rush LJ, Yu L, Liu C, et al. The MLL partial tandem duplication: evidence for recessive gain-of-function in acute myeloid leukemia identifies a novel patient subgroup for molecular-targeted therapy. Blood. 2005;106(1):345–352
  19. Marcucci G, Strout MP, Bloomfield CD, Caligiuri MA. Detection of unique ALL1 (MLL) fusion transcripts in normal human bone marrow and blood: distinct origin of normal versus leukemic ALL1 fusion transcripts. Cancer Res. 1998;58(4):790–793
  20. Basecke J, Feuring-Buske M, Brittinger G, Schaefer UW, Hiddemann W, Griesinger F. Transcription of AML1 in hematopoietic subfractions of normal adults. Ann Hematol. 2002;81(5):254–257
  21. Bose S, Deininger M, Gora-Tybor J, Goldman JM, Melo JV. The presence of typical and atypical BCR-ABL fusion genes in leukocytes of normal individuals: biologic significance and implications for the assessment of minimal residual disease. Blood. 1998;92(9):3362–3367
  22. Biernaux C, Sels A, Huez G, Stryckmans P. Very low level of major BCR-ABL expression in blood of some healthy individuals. Bone Marrow Transplant. 1996;17(Suppl. 3):S45–S47
  23. Basecke J, Cepek L, Mannhalter C, Krauter J, Hildenhagen S, Brittinger G, et al. Transcription of AML1/ETO in bone marrow and cord blood of individuals without acute myelogenous leukemia. Blood. 2002;100(6):2267–2268
  24. Weisser M, Kern W, Schoch C, Hiddemann W, Haferlach T, Schnittger S. RT-PCR based monitoring of MLL-PTD expression levels enables risk assessment in AML patients with normal karyotypes. Haematologica. 2005;90(7):881–889
  25. Basecke J, Griesinger F, Trumper L, Brittinger G. Leukemia- and lymphoma-associated genetic aberrations in healthy individuals. Ann Hematol. 2002;81(2):64–75
  26. Hope KJ, Jin L, Dick JE. Acute myeloid leukemia originates from a hierarchy of leukemic stem cell classes that differ in self-renewal capacity. Nat Immunol. 2004;5(7):738–743
  27. Terstappen LW, Huang S, Safford M, Lansdorp PM, Loken MR. Sequential generations of hematopoietic colonies derived from single nonlineage-committed CD34+CD38- progenitor cells. Blood. 1991;77(6):1218–1227
  28. Martin ME, Milne TA, Bloyer S, Galoian K, Shen W, Gibbs D, et al. Dimerization of MLL fusion proteins immortalizes hematopoietic cells. Cancer Cell. 2003;4(3):197–207

PII: S0145-2126(06)00063-4

doi: 10.1016/j.leukres.2006.02.005

Leukemia Research
Volume 30, Issue 9 , Pages 1091-1096 , September 2006

Article Tools

* Image Usage & Resolution